Commentary · 24 Jun 2025
Mini reviewPublished 11 Jul 2019
Preconception Pharmaceutical Care and Rare Diseases
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The objective of this paper is to demonstrate how both individual family physicians and pharmacists, as well as larger primary care organisations can contribute to the implementation of preconception care delivery i.e. to establish the service, to reach the target population and to add sustainably and effectively to the primary goals of preconception care i.e. to modify the risks to the health of future children and more specifically with respect to rare diseases. This paper comprises a short introduction into the contents of preconception care and a structured debate in which implementation options are will be explored such as; seizing opportunities in daily practice, integration in contraception counselling and/or sexual and reproductive health programmes; selection of and outreach to, high risk subgroups defined for example by genetic predisposition, social economic deprivation, chronic diseases etc. The readers are expected to understand options to improve preconception pharmaceutical care applicable in their own healthcare system. Community pharmacists are in a privileged position to implement pharmaceutical care to prevent rare diseases wherever possible by dispensing safe medicines and advising healthy life-style and genetic counselling before conception as well as occasionally referring to the possibility of assisted reproductive technology.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.
More from this journal
The newest in Journal of Rare Disorders: Diagnosis & Therapy.
Perspective · 24 Jun 2025
Integrative Approaches Combining Genomics for Precise Identification of Rare Diseases
Perspective · 24 Jun 2025
Utilization of Liquid Biopsy Techniques for Detecting Genetic and Protein Markers in Rare Disorders
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Rare Disorders: Diagnosis & Therapy
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Marc Dooms”
